Inceptor Bio Names Matthias Schroff CEO
09 May 2023 //
CONTRACT PHARMA
Inceptor Bio and Avectas partner for CAR-T cell therapies development
13 Oct 2022 //
PHARMACEUTICAL-TECHNOLOGY
Inceptor Bio to use $37M series A to nudge CAR-T into clinic
19 May 2022 //
FIERCEBIOTECH